Posted inBiotechnology
Kinase-Inactive RIPK3 Model Unveils Scaffold Role in Inflammation
In a groundbreaking study published in Cell Death Discovery, researchers Du, Li, Zhao, and colleagues have unveiled novel insights into…
Posted inBiotechnology
GSK explores frontiers of siRNA with $1B deal for 2 drugs from Chinese biotech
GSK is continuing to bolster its siRNA portfolio by paying $40 million upfront for a pair of oligonucleotide therapies from…
Posted inBiotechnology
US Newborn Hepatitis B Vaccination Rates Show Key Trends
In a striking turn of events that has puzzled public health experts globally, recent surveillance data reveal a significant and…
Posted inBiotechnology
Assessing Targeted HIV and Harm Reduction Services
In an era where the fight against HIV/AIDS is reaching unprecedented scientific and public health milestones, tailored interventions targeting vulnerable…
Posted inBiotechnology
Protara sees 66% 6-month bladder cancer response rate, but drops to 33% at 12 months
Protara Therapeutics has touted a 66% complete response (CR) rate for its cell therapy among certain bladder cancer patients as…
Posted inBiotechnology
Testis-Specific E3 Ligase Controls Sperm Formation, Fertility
In a groundbreaking study poised to reshape our understanding of male fertility, researchers have identified a pivotal molecular mechanism governing…
Posted inBiotechnology
Johns Hopkins Medicine Study Reveals Sex and Menopause Influence Early Lyme Disease Symptoms
Emerging Insights into Sex-Based Differences in Early Lyme Disease Presentation: A Johns Hopkins Medicine Study A groundbreaking investigation by Johns…
Posted inBiotechnology
AI-Enhanced Electronic Nose Revolutionizes Ovarian Cancer Detection
In a groundbreaking advancement in early cancer detection, researchers at Linköping University, Sweden, have developed a revolutionary machine learning-driven electronic…
Posted inBiotechnology
Team Creativity Drives Superior Patient Care, Reduces Burnout, and Boosts Job Satisfaction, Study Finds
A groundbreaking study originating from Columbia University’s Mailman School of Public Health has shed new light on the role of…
Posted inBiotechnology
Galapagos takes €228M hit from cell therapy wind-down but still has cash for dealmaking
Galapagos took a 228 million euro ($269 million) hit last year as it began to close its cell therapy business,…